TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/22/2026
Back to search
Official data from USPTO
SEMA4
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SEMA4
ST13
US500000086983080Class
1, 5, 35, 42, 44
Filing
86983080
Registration
5330559
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
71
Latest update
07/23/2026
Trademark type
Word
Nice classes
1, 5, 35, 42, 44
Filing date
06/11/2015
Registration date
11/07/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/30/2025
Last transaction
07/23/2026
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/01/2017
First use in commerce
05/01/2017
Drawing code
4
Owner type
03
Owner location
Stamford, CT, US
Examiner
FALK, JONATHAN ROBERT
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SEMA4 OPCO, INC.
MOUNT SINAI GENOMICS, INC.
Icahn School of Medicine at Mount Sinai
Representatives
Lisa C. Pavento Meunier Carlin & Curfman LLC
Technical classification
Nice Classes
Class 1Class 5Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Kits containing chemical and biochemical assays and reagents for scientific research use; nucleic acid and protein isolation kits comprised primarily of assays and reagents for use in epigenetic research and analysis; none of the aforementioned involve the use or study of semaphorins
Class 5
Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseasescancer and Mendelian disorders; test kits consisting of medical diagnostic reagents and assays for testing in the field of the prevention and treatment of disorders and diseases; none of the aforementioned involve the use or study of semaphorins
Class 35
Business consulting and business information services regarding precision health diagnosis and personalized treatment; business consulting and business information services regarding the analysis and packaging of health data; providing business informationcommercial corporate and statistical information provided on-line from a computer database or the Internet; statistical analysis and reporting services for business purposes; business consulting and business information services regarding the identification of drug targets; business consulting and business information services regarding bioinformatic analysis; population health management
Class 42
Medical and scientific research in the field of biologic testing and interpretationdiagnosistreatmenthealth maintenance; bioinformatics interpretation of health data; medical and scientific research in the field of ancestry analysis for scientific research purposes; compiling data for research purposes in the field of medical science and medical consultancy for use in connection with diagnostic testing; analysis and screening of nucleic acids for scientific research purposes; genome mapping for scientific purposes; providing information in the field of disease classification for use in connection with diagnostic testing ; development of scientific research and technology for purposes of disease diagnosispreventative health carehealth monitoringpersonalized treatment; providing a website featuring non-downloadable software for patient access to health care services and health information; providing a website featuring non-downloadable software for patient access to diagnosistreatmenthealth maintenance information; providing a website featuring non-downloadable software for accessingviewinginteracting with and downloading personal health recordsdiagnosestreatment planshealth monitoring information; scientific and medical researchidentifying drug targets; scientific research relating to population health management; none of the aforementioned involve the use or study of semaphorins
Class 44
Diagnostic services in the field of medicine; medical testing for diagnosis of diseases and treatment purposes ; bioinformatics analysis for medical diagnostic and personalized treatment purposes; biochemical testing for ancestry analysis and personalized diagnostics and treatments; nucleic acid analysis and screening for medical diagnostic and treatment purposes; DNA analysis and screening for medical diagnostic and treatment purposes; consulting services in the field of biological sequence and bioinformatic processing for medical diagnosis and treatment purposes; health care servicesleveraging health monitoring and data science to provide optimal health and disease prevention to patients; creating personalized preventative health-care programs and disease management programs; providing an online resource center featuring personalized health information based on health information and diagnostics; medical testingidentifying drug targets for diagnostic or treatment purposes; none of the aforementioned involve the use or study of semaphorins
Publications
History of USPTO decisions and trademark events.
71 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/22/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/22/2026
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
06/01/2026
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
06/01/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/01/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/01/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/01/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
01/30/2025
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
01/30/2025
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
01/30/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/30/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/28/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/28/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/28/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/28/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/28/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/28/2024
ES8R
TEAS SECTION 8 RECEIVED
05/07/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/08/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/07/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/10/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/10/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/10/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/04/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
05/07/2018
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/07/2018
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
12/27/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/27/2017
FAXX
FAX RECEIVED
11/27/2017
ES7R
TEAS SECTION 7 REQUEST RECEIVED
11/20/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
11/07/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/30/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/29/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/13/2017
DPCC
DIVISIONAL PROCESSING COMPLETE
09/13/2017
IUAF
USE AMENDMENT FILED
09/11/2017
DRRR
DIVISIONAL REQUEST RECEIVED
09/11/2017
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
09/11/2017
EISU
TEAS STATEMENT OF USE RECEIVED
09/11/2017
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/30/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/17/2017
EX2G
SOU EXTENSION 2 GRANTED
03/15/2017
EXT2
SOU EXTENSION 2 FILED
03/15/2017
EEXT
SOU TEAS EXTENSION RECEIVED
03/15/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/30/2016
EX1G
SOU EXTENSION 1 GRANTED
11/29/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/28/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/20/2016
NREV
NOTICE OF REVIVAL - E-MAILED
10/20/2016
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
10/20/2016
PETG
PETITION TO REVIVE-GRANTED
10/20/2016
PROA
TEAS PETITION TO REVIVE RECEIVED
10/20/2016
MAB6
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
10/17/2016
ABN6
ABANDONMENT - NO USE STATEMENT FILED
10/17/2016
EXT1
SOU EXTENSION 1 FILED
09/15/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/15/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/19/2016
PUBO
PUBLISHED FOR OPPOSITION
01/19/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/30/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/15/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/10/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/08/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/08/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/16/2015
GNRT
NON-FINAL ACTION E-MAILED
07/16/2015
CNRT
NON-FINAL ACTION WRITTEN
07/16/2015
DOCK
ASSIGNED TO EXAMINER
07/11/2015
MPMK
NOTICE OF PSEUDO MARK E-MAILED
06/16/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/15/2015
NWAP
NEW APPLICATION ENTERED
06/15/2015
Continuous trademark protection
Get notified about every new filing that threatens SEMA4 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.